Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arsenal Capital Partners is a leading private equity firm specializing in building and investing in high-growth healthcare and industrial businesses. It focuses on technology-rich strategies and has completed numerous acquisitions of life science service providers, pharma services firms, and healthcare technology businesses.
Recent notable deals include the acquisition of Fortrea’s enabling services segment and patient access businesses for up to $345 million in 2024, as well as investments in BioIVT—a provider of biological products for drug discovery—and Rancho BioSciences—a data curation company serving biopharma clients. The firm manages multiple funds with billions under management.
As an investor rather than an operator or developer, clinical results or pipeline are not directly relevant at the parent level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arsenal Capital Partners.